IMS Health Holdings Inc, backed by TPG Capital Funds LP, filed with U.S. regulators to raise up to $100 million in an initial public offering of its common stock. IMS provides prescription data to the pharmaceutical industry, medical device makers, government agencies and other companies in the healthcare sector. Founded in 1954, the company has over 5,000 clients and operates in more than 100 countries, according to its website.TPG, Canada Pension Plan Investment Board (CPPIB) and Leonard Green & Partners LP took IMS private in 2010 for $5.2 billion, including debt.Danbury, Connecticut-based IMS Health told the U.S Securities and Exchange Commission in a preliminary prospectus that JP Morgan, Goldman Sachs, Morgan Stanley and BofA Merrill Lynch were among the underwriters for the IPO. ()Reuters reported last month that the company hired JPMorgan to lead a proposed IPO that could value the private equity-owned healthcare information company at close to $10 billion.
Morgan Stanley is a global financial services company that, through its subsidiaries and affiliates, provides its products and services to a range of clients and customers, including corporations, governments, financial institutions and individuals. Shares of MS fell by 1.05% or $-0.33/share to $31.03. In the past year, the shares have traded as low as $19.32 and as high as $31.85. On average, 11819500 shares of MS exchange hands on a given day and today's volume is recorded at 9649061.
Source
